ESAB Corporation filings document the regulatory record for an industrial manufacturer of welding, cutting and joining equipment and consumables. Its Form 8-K disclosures cover operating and financial results, material-event reporting, dividend and capital-structure matters, senior unsecured notes and related subsidiary guarantees.
Proxy and governance filings describe shareholder voting matters, director and officer changes, board committee assignments, executive compensation, director independence and related governance practices. The filing record also reflects public-company reporting following ESAB's 2022 registration as a standalone issuer.
ESAB Corp President and CEO Shyam Kambeyanda reported routine equity compensation activity involving restricted stock units (RSUs). On the reported date, RSUs covering 10,796 shares of common stock vested and were exercised into common shares at a conversion price of $0.00 per share. To cover associated tax obligations, ESAB Corporation withheld 5,053 shares through a net share settlement, as described in the footnotes, and no shares were sold by Kambeyanda on the market to satisfy this tax liability. Following these transactions, he holds 124,944 shares of ESAB common stock directly. The RSU award vests in three equal annual installments, with all remaining RSUs from this grant scheduled to vest on May 12, 2027.
ESAB Corp SVP and General Counsel Curtis E. Jewell exercised equity awards and had shares withheld for taxes. On May 12, 2026, he exercised 1,822 restricted stock units into the same number of common shares. In connection with this vesting, 894 shares were withheld by ESAB to cover tax liabilities through net share settlement, and no shares were sold on the market. After these transactions, Jewell directly owned 19,639 common shares and also had 355.835 shares held indirectly through a 401K plan. The restricted stock unit award continues to vest in three equal annual installments, with all remaining units from this award scheduled to vest on May 12, 2027.
ESAB Corp Chief Human Resources Officer Michele Campion reported routine equity compensation activity involving restricted stock units. She exercised RSUs covering 1,835 shares of common stock, converting them into directly held shares. In connection with the vesting, 902 shares were withheld by ESAB at a price of $94.20 per share to satisfy her tax liability; no shares were sold in the market. Following these transactions, she directly holds 16,108 shares of common stock and 1,836 restricted stock units that continue to vest according to their schedule.
ESAB Corp President, Fab Tech Olivier Biebuyck reported routine equity compensation activity. He exercised 2,362 restricted stock units, receiving the same number of ESAB common shares. In connection with this vesting, 1,184 shares were withheld by ESAB to cover tax obligations, rather than sold in the market.
After these transactions, Biebuyck holds 21,740 ESAB common shares directly. Footnotes state that the restricted stock units vest in three equal annual installments and that remaining units from this award are scheduled to vest on May 12, 2027, reflecting ongoing stock-based compensation rather than discretionary trading.
ESAB Corporation reported the voting results from its 2026 Annual Meeting of Stockholders. Shareholders elected nine directors to the board, with each nominee receiving over 55 million votes in favor and broker non-votes recorded on the proposals.
Stockholders also ratified the appointment of Ernst & Young LLP as independent registered public accounting firm for the year ending December 31, 2026, with 58,527,946 votes for and 107,989 against. In addition, shareholders approved, on a non-binding advisory basis, the compensation of the company’s named executive officers, with 53,998,529 votes for and 3,548,562 against.
ESAB Corp director Stephanie M. Phillipps reported routine equity compensation awards. She received 813 deferred stock units, each representing one share of ESAB common stock. She also received 2,647 stock options with a $100.94 exercise price that vested and became exercisable on the grant date. The deferred stock units vest in a single installment on June 1, 2027 and will be settled in common stock after her separation from the company.
ESAB Corp director Sebastien Martin received new equity awards. On May 8, 2026, he was granted 813 restricted stock units, each representing one share of ESAB common stock, and stock options for 2,647 shares at an exercise price of $100.94 per share.
The stock options vested and became exercisable on the grant date and expire on May 7, 2033. The restricted stock units vest in a single installment on June 1, 2027, aligning part of the director’s compensation with ESAB’s future share performance.
ESAB Corp director Melissa Cummings received new equity awards as part of her compensation. On May 8, 2026, she was granted 813 restricted stock units and 2,647 stock options linked to ESAB common stock.
The stock options carry an exercise price of $100.94 per share, vested and became exercisable on the grant date, and are scheduled to expire on May 7, 2033. The restricted stock units each represent a contingent right to receive one share of ESAB common stock and are set to vest in a single installment on June 1, 2027.
These awards are classified as acquisitions under a grant or award, not as open‑market purchases or sales, and result in post‑grant derivative holdings of 813 restricted stock units and 2,647 stock options directly owned by Cummings.
ESAB Corp director Rajiv Vinnakota reported receiving new equity awards. On May 8, 2026, he was granted 813 Restricted Stock Units, each representing one share of ESAB common stock. These RSUs vest in a single installment on June 1, 2027.
On the same date, he also received 2,647 stock options with an exercise price of $100.94 per share. According to the disclosure, these options vested and became exercisable on the grant date and expire on May 7, 2033. After these grants, his reported holdings include 813 RSUs and 2,647 options, all held directly.
ESAB Corp director Didier P. Teirlinck received new equity awards as part of his compensation. On May 8, 2026, he was granted 406 restricted stock units and 407 deferred stock units, each representing a contingent right to receive one share of ESAB common stock.
The restricted and deferred stock units vest in a single installment on June 1, 2027, with the deferred units to be settled in ESAB common stock after his separation from the company. He also received stock options for 2,647 shares at an exercise price of $100.94 per share, which vested and became exercisable on the grant date and expire on May 7, 2033.